Technology
Health
Biotechnology
Rubius Therapeutics
$16.319876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$16.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.13 (-6.48%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell RUBY and other stocks, options, ETFs, and crypto commission-free!
About
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan and is headquartered in Cambridge, MA.
Employees
65
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
1.38B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
271.02K
High Today
$17.50
Low Today
$15.87
Open Price
$17.50
Volume
167.00K
52 Week High
$33.01
52 Week Low
$12.71
Collections
Technology
Health
Biotechnology
Therapy
Cancer Prevention
2018 IPO
US
North America
Price Paid on Robinhood
14% Lower
Right Now
52 Week Low
$12.71
Average Price Paid
$18.87
52 Week High
$33.01
Earnings
-$3.33
-$2.32
-$1.32
-$0.31
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.42 per share
Actual
Available Mar 28, Pre-Market